135 related articles for article (PubMed ID: 35397740)
1. Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease.
Ensenyat-Mendez M; Rünger D; Orozco JIJ; Le J; Baker JL; Weidhaas J; Marzese DM; DiNome ML
Ann Surg Oncol; 2022 Aug; 29(8):4716-4724. PubMed ID: 35397740
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
Orozco JIJ; Le J; Ensenyat-Mendez M; Baker JL; Weidhaas J; Klomhaus A; Marzese DM; DiNome ML
Ann Surg Oncol; 2022 Oct; 29(10):6407-6414. PubMed ID: 35842534
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery.
Angarita S; Ye L; Rünger D; Hadaya J; Baker JL; Dawson N; Thompson CK; Lee MK; Attai DJ; DiNome ML
Ann Surg Oncol; 2021 May; 28(5):2609-2618. PubMed ID: 33084993
[TBL] [Abstract][Full Text] [Related]
4. Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer.
Ye L; Rünger D; Angarita SA; Hadaya J; Baker JL; Lee MK; Thompson CK; Attai DJ; DiNome ML
Breast Cancer Res Treat; 2022 Jun; 193(2):429-436. PubMed ID: 35389189
[TBL] [Abstract][Full Text] [Related]
5. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
[No Abstract] [Full Text] [Related]
6. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
8. Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment?
Liberale V; Rosso R; Arisio R; D'Alonzo M; Villasco A; Fuso L; De Sanctis C; Modaffari P; Biglia N
Breast J; 2020 Feb; 26(2):168-175. PubMed ID: 31448500
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
[TBL] [Abstract][Full Text] [Related]
10. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
[TBL] [Abstract][Full Text] [Related]
11. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
12. [The importance of the extracapsular extension of the sentinel node metastasis in the surgical treatment of breast cancer].
Maráz R; Venczel L; Sikorszki L; Ambrózay É; Serfőző O; Rajtár M; Cserni G
Magy Seb; 2020 Mar; 73(1):16-22. PubMed ID: 32172574
[TBL] [Abstract][Full Text] [Related]
13. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
14. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
[TBL] [Abstract][Full Text] [Related]
16. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
[TBL] [Abstract][Full Text] [Related]
17. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
18. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
[TBL] [Abstract][Full Text] [Related]
19. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
20. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer.
Kantor O; Wakeman M; Weiss A; Wong S; Laws A; Grossmith S; Mittendorf EA; King TA
Ann Surg Oncol; 2021 Mar; 28(3):1358-1367. PubMed ID: 32869154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]